Is ServiceNow Stock a Buy After Its Brutal First Half?

ServiceNow’s Q1 2026 subscription revenue rose 22% YoY to $3.67B, and cRPO increased 22.5% to $12.64B, signaling strong demand despite an earlier AI-driven software sell-off. Now Assist AI is tracking to ~$1.5B annual contract value in 2026 (vs. a prior $1B target), with customers spending >$1M/year on Now Assist up 130% YoY. For 2026, management guided subscription revenue of ~$15.75B (+20%+) and a 44% free-cash-flow margin in Q1, but the stock is still valued at ~24x forward P/E and ~7x P/S, keeping the risk elevated even as the AI fears appear to be easing.

Analysis

The market is still treating AI as a binary substitute threat, but for workflow platforms the more important variable is billing architecture. A product mix that increasingly charges on workflow volume, tokens, and connectors makes AI adoption accretive to usage, which is the opposite of the seat-based disruption narrative that has crushed valuations across software. That creates a relative winner set: platform vendors with embedded process ownership and deep integrations should be more resilient than point solutions whose value is easier to bundle away.

The near-term setup is still fragile. Over the next 1-3 months, the stock will likely trade on whether AI monetization converts into sustained cRPO acceleration and larger deal cadence rather than on headline AI enthusiasm; if that stops improving, the multiple can compress again even with solid growth. The 6-18 month risk is re-bundling, not replacement: hyperscalers and suite vendors can still use model access to pull workflow spend into broader platforms, which would pressure premium SaaS names without necessarily breaking the business.

Consensus may be underestimating how much of the current re-rating already reflects a softer AI scare. This looks more like a quality compounder with an unresolved valuation problem than an obvious re-entry point, so upside is likely incremental rather than explosive unless management keeps beating the AI monetization targets by a wide margin. The thesis is falsified if AI-related ACV growth stalls, subscription growth decelerates into the mid-teens, or broader software multiples roll over on a renewed frontier-AI disruption headline.

Key Decisions for Investors

• Maintain only a starter long in NOW on weakness; treat it as a quality compounder, not a conviction rebuy until the next quarter confirms AI attach rates and large-deal conversion. Upside is more likely 10-15% over 3-6 months than a full rerate, while downside remains 15-20% if AI fears reappear.
• Pair trade: long NOW / short a basket of more vulnerable enterprise software names (e.g., WDAY, HUBS) on any renewed AI-disruption selloff. The relative thesis is that workflow ownership and usage-based monetization should preserve revenue quality better than seat-centric models.
• If entering outright exposure, prefer a staged entry or cash-secured put sale rather than chasing strength. The stock still screens as expensive versus its growth deceleration, so volatility premium is likely still attractive for patient buyers.
• Set a watch item on the next earnings print: if Now Assist monetization fails to outgrow the overall subscription base, exit the bullish thesis quickly. That would indicate AI is becoming a feature, not an economic driver.